Emerson (EMR) insider to sell 22,500 shares valued at $3.33M

Rhea-AI Filing Summary

Emerson Electric insider plans to sell shares under Rule 144. A notice was filed for the proposed sale of 22,500 shares of Emerson common stock through Charles Schwab on or about 02/12/2026, with an aggregate market value of $3,332,925.00. Shares outstanding were 562,000,000.

The shares to be sold were acquired via vesting of restricted stock and performance share awards on 11/03/2025 and 02/02/2026 as equity compensation. The seller, Surendralal Lanca Karsanbhai, reported selling 7,263 common shares in the past three months for gross proceeds of $965,979.00 and affirmed knowledge of no undisclosed material adverse information.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corp 3000 Schwab Way Westlake TX 76262	22500	3332925.00	562000000	02/12/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/02/2026	Vesting of Restricted Stock Award	Issuer			5578	02/02/2026	Equity Compensation
Common	11/03/2025	Vesting of Performance Share Award	Issuer			16922	11/03/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Surendralal Lanca Karsanbhai 8027 FORSYTH BLVD. St. Louis MO 63105	Common	12/03/2025	7263	965979.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the EMR Form 144 filing disclose about planned share sales?

The filing discloses an intended sale of 22,500 shares of Emerson common stock under Rule 144. The proposed sale, through Charles Schwab, has an aggregate market value of $3,332,925.00 and is expected around 02/12/2026 on the New York Stock Exchange.

How many Emerson (EMR) shares has the insider already sold recently?

The insider reported selling 7,263 shares of Emerson common stock in the past three months. These sales generated gross proceeds of $965,979.00. This disclosure helps investors understand recent liquidity actions in addition to the newly planned 22,500-share sale under Rule 144.

How were the Emerson (EMR) shares in this Form 144 acquired?

The shares were acquired through equity compensation, specifically vesting of restricted stock and performance share awards. Vesting occurred on 11/03/2025 and 02/02/2026. This means the insider did not buy these shares in the open market but earned them as part of compensation.

What is the size of the planned EMR sale relative to shares outstanding?

The notice covers a proposed sale of 22,500 common shares, while 562,000,000 shares were outstanding. This shows the intended sale is a small fraction of total shares, providing context for the potential impact of the insider’s planned transaction.

Who is the seller in the Emerson (EMR) Rule 144 notice and what do they certify?

The seller is Surendralal Lanca Karsanbhai. By signing the notice, this person represents that they do not know any material adverse information about Emerson’s current or prospective operations that has not been publicly disclosed, consistent with Rule 144 and related trading plan representations.